HIV Citation List: April 26 - May 9, 2013
PubMed citations
1. 2'-Deoxythymidine Adducts from the anti-HIV Drug Nevirapine. Antunes, A.M., B. Wolf, M.C. Oliveira, F.A. Beland, and M.M. Marques. Molecules, 2013. 18(5): p. 4955-4971. PMID[23624649].
[PubMed]. HIV_0426-050913.
2. Diaryltriazine Non-Nucleoside Reverse Transcriptase Inhibitors Are Potent Candidates for Pre-exposure Prophylaxis in the Prevention of Sexual HIV Transmission. Arien, K.K., M. Venkatraj, J. Michiels, J. Joossens, K. Vereecken, P. Van der Veken, S. Abdellati, V. Cuylaerts, T. Crucitti, L. Heyndrickx, J. Heeres, K. Augustyns, P.J. Lewi, and G. Vanham. The Journal of Antimicrobial Chemotherapy, 2013. [Epub ahead of print]. PMID[23645585].
[PubMed]. HIV_0426-050913.
3. Probing a Chemical Space for Fragmental Topology-activity Landscapes (FRAGTAL): Application for Diketo Acid and Catechol HIV Integrase Inhibitor Offspring Fragments. Bak, A., T. Magdziarz, A. Kurczyk, K. Serafin, and J. Polanski. Combinatorial Chemistry & High Throughput Screening, 2013. 16(4): p. 274-287. PMID[23330876].
[PubMed]. HIV_0426-050913.
4. Discovery of Piperidine-linked Pyridine Analogues as Potent Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. Chen, X., Y. Li, S. Ding, J. Balzarini, C. Pannecouque, E. De Clercq, H. Liu, and X. Liu. ChemMedChem, 2013. [Epub ahead of print]. PMID[23650275].
[PubMed]. HIV_0426-050913.
5. Prophylactic Efficacy of Oral Emtricitabine (FTC) and Tenofovir Disoproxil Fumarate (TDF) Combination against a Tenofovir-resistant SHIV Containing the K65R Mutation in Macaques. Cong, M.E., J. Mitchell, E. Sweeney, S. Bachman, D.L. Hanson, W. Heneine, and J.G. Garcia-Lerma. The Journal of Infectious Diseases, 2013. [Epub ahead of print]. PMID[23633402].
[PubMed]. HIV_0426-050913.
6. Synergistic Activity of Carbosilane Dendrimers in Combination with Maraviroc against HIV in Vitro. Cordoba, E.V., E. Arnaiz, F.J. De La Mata, R. Gomez, M. Leal, M. Pion, and M.A. Munoz-Fernandez. AIDS, 2013. [Epub ahead of print]. PMID[23612005].
[PubMed]. HIV_0426-050913.
7. Elucidating a Relationship between Conformational Sampling and Drug Resistance in HIV-1 Protease. de Vera, I.M., A.N. Smith, M.C. Dancel, X. Huang, B.M. Dunn, and G.E. Fanucci. Biochemistry, 2013. [Epub ahead of print]. PMID[23566104].
[PubMed]. HIV_0426-050913.
8. Development and Validation of a Stability Indicating Method for Seven Novel Derivatives of Lamivudine with anti-HIV and anti-HBV Activity in Simulated Gastric and Intestinal Fluids. Gualdesi, M.S., J. Esteve-Romero, M.C. Brinon, and M.A. Raviolo. Journal of Pharmaceutical and Biomedical Analysis, 2013. 78-79: p. 52-56. PMID[23454677].
[PubMed]. HIV_0426-050913.
9. Cationic Host Defence Peptides: Potential as Antiviral Therapeutics. Gwyer Findlay, E., S.M. Currie, and D.J. Davidson. BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, 2013. [Epub ahead of print]. PMID[23649937].
[PubMed]. HIV_0426-050913.
10. Nucleotide Competing Reverse Transcriptase Inhibitors: Discovery of a Series of Non-basic Benzofurano[3,2-d]pyrimidin-2-one Derived Inhibitors. James, C.A., P. Deroy, M. Duplessis, P.J. Edwards, T. Halmos, J. Minville, L. Morency, S. Morin, B. Simoneau, M. Tremblay, R. Bethell, M. Cordingley, J. Duan, L. Lamorte, A. Pelletier, D. Rajotte, P. Salois, S. Tremblay, and C.F. Sturino. Bioorganic & Medicinal Chemistry Letters, 2013. 23(9): p. 2781-2786. PMID[23545107].
[PubMed]. HIV_0426-050913.
11. Self-delivery Multifunctional anti-HIV Hydrogels for Sustained Release. Li, J., X. Li, Y. Kuang, Y. Gao, X. Du, J. Shi, and B. Xu. Advanced Healthcare Materials, 2013. [Epub ahead of print]. PMID[23616384].
[PubMed]. HIV_0426-050913.
12. Daphnane Diterpenoids from the Stems of Trigonostemon lii and Their anti-HIV-1 Activity. Li, S.F., Y. Zhang, N. Huang, Y.T. Zheng, Y.T. Di, S.L. Li, Y.Y. Cheng, H.P. He, and X.J. Hao. Phytochemistry, 2013. [Epub ahead of print]. PMID[23628626].
[PubMed]. HIV_0426-050913.
13. Anti-HIV and NO Production Inhibition Activities of Epi-aleuritolic acid Derivatives. Liu, J.B., Y. Zhang, B.S. Cui, Y.L. Cao, S.P. Yuan, Y. Guo, Q. Hou, and S. Li. Journal of Asian Natural Products Research, 2013. [Epub ahead of print]. PMID[23639006].
[PubMed]. HIV_0426-050913.
14. Exploiting Drug-resistant Enzymes as Tools to Identify Thienopyrimidinone Inhibitors of Human Immunodeficiency Virus Reverse Transcriptase-associated Ribonuclease H. Masaoka, T., S. Chung, P. Caboni, J. Rausch, J.A. Wilson, H. Taskent-Sezgin, J.A. Beutler, G. Tocco, and S.F. Le Grice. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23631411].
[PubMed]. HIV_0426-050913.
15. Scaffold Optimization in Discontinuous Epitope Containing Protein Mimics of gp120 Using Smart Libraries. Mulder, G.E., H.L. Quarles van Ufford, J. van Ameijde, A.J. Brouwer, J.A. Kruijtzer, and R.M. Liskamp. Organic & Biomolecular Chemistry, 2013. 11(16): p. 2676-2684. PMID[23467699]. [PubMed]. HIV_0426-050913.
16. CD4 Mimics as HIV Entry Inhibitors: Lead Optimization Studies of the Aromatic Substituents. Narumi, T., H. Arai, K. Yoshimura, S. Harada, Y. Hirota, N. Ohashi, C. Hashimoto, W. Nomura, S. Matsushita, and H. Tamamura. Bioorganic & Medicinal Chemistry, 2013. 21(9): p. 2518-2526. PMID[23535561].
[PubMed]. HIV_0426-050913.
17. Hyptis verticillata Jacq: A Review of Its Traditional Uses, Phytochemistry, Pharmacology and Toxicology. Picking, D., R. Delgoda, I. Boulogne, and S. Mitchell. Journal of Ethnopharmacology, 2013. 147(1): p. 16-41. PMID[23403358].
[PubMed]. HIV_0426-050913.
18. Identification of Benzofurano[3,2-d]pyrimidin-2-ones, a New Series of HIV-1 Nucleotide-competing Reverse Transcriptase Inhibitors. Tremblay, M., R.C. Bethell, M.G. Cordingley, P. Deroy, J. Duan, M. Duplessis, P.J. Edwards, A.M. Faucher, T. Halmos, C.A. James, C. Kuhn, J.E. Lacoste, L. Lamorte, S.R. Laplante, E. Malenfant, J. Minville, L. Morency, S. Morin, D. Rajotte, P. Salois, B. Simoneau, S. Tremblay, and C.F. Sturino. Bioorganic & Medicinal Chemistry Letters, 2013. 23(9): p. 2775-2780. PMID[23511023].
[PubMed]. HIV_0426-050913.
19. Burkholderia oklahomensis Agglutinin Is a Canonical Two-domain OAA-family Lectin: Structures, Carbohydrate Binding and anti-HIV Activity. Whitley, M.J., W. Furey, S. Kollipara, and A.M. Gronenborn. The FEBS Journal, 2013. 280(9): p. 2056-2067. PMID[23480609].
[PubMed]. HIV_0426-050913.
20. A Convenient Synthesis of N-linked Diglycose Derivatives Based on One-pot Tandem Staudinger/aza-Wittig/reduction and Biological Evaluation. Zhang, P., Y. Li, M. Liu, Y. Wang, C. Li, D. Ma, H. Chen, K. Wang, X. Li, and J. Zhang. Carbohydrate Research, 2013. 372: p. 15-22. PMID[23524106].
[PubMed]. HIV_0426-050913.
ISI Web of Knowledge Citations
21. 3D-QSAR, CoMFA, and CoMSIA of New Phenyloxazolidinones Derivatives as Potent HIV-1 Protease Inhibitors. Abedi, H., H. Ebrahimzadeh, and J.B. Ghasemi. Structural Chemistry, 2013. 24(2): p. 433-444. ISI[000316401700008].
[WOS]. HIV_0426-050913.
22. Phenylethanoids from the Flowers of Rosa rugosa and Their Biological Activities. Gao, X.M., L.D. Shu, L.Y. Yang, Y.Q. Shen, Y.J. Zhang, and Q.F. Hu. Bulletin of the Korean Chemical Society, 2013. 34(1): p. 246-248. ISI[000316430100044].
[WOS]. HIV_0426-050913.
23. Aurones and Isoaurones from the Flowers of Rosa damascena and Their Biological Activities. Gao, X.M., L.Y. Yang, X.Z. Huang, L.D. Shu, Y.Q. Shen, Q.F. Hu, and Z.Y. Chen. Heterocycles, 2013. 87(3): p. 583-589. ISI[000317026600007].
[WOS]. HIV_0426-050913.
24. Synthesis, Stereochemistry, Structural Classification, and Chemical Reactivity of Natural Pterocarpans. Goel, A., A. Kumar, and A. Raghuvanshi. Chemical Reviews, 2013. 113(3): p. 1614-1640. ISI[000316243600008].
[WOS]. HIV_0426-050913.
25. Substituted Benzothiazoles: Synthesis and Medicinal Characteristics. Henary, M., S. Paranjpe, and E.A. Owens. Heterocyclic Communications, 2013. 19(2): p. 89-99. ISI[000316996700002].
[WOS]. HIV_0426-050913.
26. Nelfinavir Augments Proteasome Inhibition by Bortezomib in Myeloma Cells and Overcomes Bortezomib and Carfilzomib Resistance. Kraus, M., J. Bader, H. Overkleeft, and C. Driessen. Blood Cancer Journal, 2013. 3. ISI[000317039700001].
[WOS]. HIV_0426-050913.
27. 5 '-Nor Carbocyclic Nucleosides: Unusual Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase. Matyugina, E.S., V.T. Valuev-Elliston, D.A. Babkov, M.S. Novikov, A.V. Ivanov, S.N. Kochetkov, J. Balzarini, K.L. Seley-Radtke, and A.L. Khandazhinskaya. MedChemComm, 2013. 4(4): p. 741-748. ISI[000316868900017].
[WOS]. HIV_0426-050913.
28. Discovery of an HIV Integrase Inhibitor with an Excellent Resistance Profile. Pryde, D.C., R. Webster, S.L. Butler, E.J. Murray, K. Whitby, C. Pickford, M. Westby, M.J. Palmer, D.J. Bull, H. Vuong, D.C. Blakemore, D. Stead, C. Ashcroft, I. Gardner, C. Bru, W.Y. Cheung, I.O. Roberts, J. Morton, and R.A. Bissell. MedChemComm, 2013. 4(4): p. 709-719. ISI[000316868900012].
[WOS]. HIV_0426-050913.
29. Computational Study and Peptide Inhibitors Design for the CDK9-cyclin T1 Complex. Randjelovic, J., S. Eric, and V. Savic. Journal of Molecular Modeling, 2013. 19(4): p. 1711-1725. ISI[000316677600024].
[WOS]. HIV_0426-050913.
30. Nerium oleander Derived Cardiac Glycoside Oleandrin Is a Novel Inhibitor of HIV Infectivity. Singh, S., S. Shenoy, P.N. Nehete, P.Y. Yang, B. Nehete, D. Fontenot, G.J. Yang, R.A. Newman, and K.J. Sastry. Fitoterapia, 2013. 84: p. 32-39. ISI[000316531400006].
[WOS]. HIV_0426-050913.
31. Small Organic Molecules Targeting PCAF Bromodomain as Potent Inhibitors of HIV-1 Replication. Wang, Q., R.R. Wang, B.Q. Zhang, S. Zhang, Y.T. Zheng, and Z.Y. Wang. MedChemComm, 2013. 4(4): p. 737-740. ISI[000316868900016].
[WOS]. HIV_0426-050913.
Patent Citations
32. Preparation of Spiro Bicyclic Diamine Derivatives as HIV Attachment Inhibitors. Wang, T., Z. Zhang, D.R. Langley, J.F. Kadow, and N.A. Meanwell. Patent. 2013. 2012-US52603 2013033059: 90pp.
[Patent]. HIV_0426-050913.
33. Novel Betulinic acid Derivatives with Antiviral Activity. Liu, Z., N.A. Meanwell, and A. Regueiro-Ren. Patent. 2013. 2012-623165 20130072465: 26pp.
[Patent]. HIV_0426-050913.
34. Substituted-benzoheterocycle Derivatives, Preparation, and Application for Preparation of Antiviral or Antineoplastic Drugs. Li, Z., X. Ji, S. Xue, P. Tao, and Z. Wang. Patent. 2013. 2012-10283171 102952062: 88pp.
[Patent]. HIV_0426-050913.
35. Preparation of 5-(Thiazol-2-yl)-3,4-dihydropyrimidones as HIV Replication Inhibitors Useful in the Treatment of HIV Infections. Heil, M.L., N.D.P. Cosford, N. Pagano, and P. Teriete. Patent. 2013. 2012-US52482 2013033003: 81pp.
[Patent]. HIV_0426-050913.
36. Preparation of Pyrrolopyridinone Compounds and Methods for Treating HIV. Haydar, S.N., B.A. Johns, and E.J. Velthuisen. Patent. 2013. 2012-US55838 2013043553: 180pp.
[Patent]. HIV_0426-050913.
37. Fluorenone-like Compound, and Preparation Method and Application Thereof. Gao, X., Q. Hu, Y. Li, G. Li, and X. Huang. Patent. 2013. 2013-10014162 103012099: 17pp.
[Patent]. HIV_0426-050913.
38. Lignans Compounds, Their Preparation Method and Application in Preparation of anti-AIDS Drugs. Gao, X. and Q. Hu. Patent. 2013. 2013-10014125 103012118: 16pp.
[Patent]. HIV_0426-050913.
39. N4 Derivatives of Deoxycytidine Prodrugs as anti-HIV and Antitumor Agents. Fromhold, M. and J. Partridge. Patent. 2013. 2012-US54277 2013036846: 42pp.
[Patent]. HIV_0426-050913.
40. HIV Inhibitors. Debnath, A.K., F. Curreli, P.D. Kwong, and Y.D. Kwong. Patent. 2013. 2012-US54009 2013036676: 102pp.
[Patent]. HIV_0426-050913.
41. Purine Nucleoside Analog Inhibitors of Retroviral Reverse Transcriptase for the Treatment of a Viral Infection and Mutations Associated with Sensitivity to These Inhibitors. Calvez, V., A.G. Marcelin, C. Soulie, M. Etheve Quelquejeu, and M. Sollogoub. Patent. 2013. 2011-59622 2981650: 21pp.
[Patent]. HIV_0426-050913.
42. Preparation of Derivatives of 3-O-(3',3'-Dimethylsuccinyl)-betulinic acid for the Treatment of HIV. Bouaziz, S., P. Coric, P. Boulanger, S.-S. Hong, and S. Turcaud. Patent. 2013. 2011-306138 2567965: 32pp.
[Patent]. HIV_0426-050913.
43. Catechol Diethers as Potent anti-HIV Agents. Patent. 2013. 2012-US59886 2013056003: 106pp.
[Patent]. HIV_0426-050913.